CN104853746B - 用于治疗红斑痤疮的组合物 - Google Patents

用于治疗红斑痤疮的组合物 Download PDF

Info

Publication number
CN104853746B
CN104853746B CN201280077293.2A CN201280077293A CN104853746B CN 104853746 B CN104853746 B CN 104853746B CN 201280077293 A CN201280077293 A CN 201280077293A CN 104853746 B CN104853746 B CN 104853746B
Authority
CN
China
Prior art keywords
composition
alcohol
weight
oil
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN201280077293.2A
Other languages
English (en)
Chinese (zh)
Other versions
CN104853746A (zh
Inventor
哈南·塞尔特库克
奥弗·托莱达诺
哈伊姆·巴尔-西曼托夫
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sol Gel Technologies Ltd
Original Assignee
Sol Gel Technologies Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sol Gel Technologies Ltd filed Critical Sol Gel Technologies Ltd
Priority to CN201810145665.XA priority Critical patent/CN108159425A/zh
Publication of CN104853746A publication Critical patent/CN104853746A/zh
Application granted granted Critical
Publication of CN104853746B publication Critical patent/CN104853746B/zh
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poly(lactide-co-glycolide)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/327—Peroxy compounds, e.g. hydroperoxides, peroxides, peroxyacids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5089—Processes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Inorganic Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CN201280077293.2A 2012-11-27 2012-11-27 用于治疗红斑痤疮的组合物 Active CN104853746B (zh)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201810145665.XA CN108159425A (zh) 2012-11-27 2012-11-27 用于治疗红斑痤疮的组合物

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/IL2012/050479 WO2014083557A1 (en) 2012-11-27 2012-11-27 Compositions for the treatment of rosacea

Related Child Applications (1)

Application Number Title Priority Date Filing Date
CN201810145665.XA Division CN108159425A (zh) 2012-11-27 2012-11-27 用于治疗红斑痤疮的组合物

Publications (2)

Publication Number Publication Date
CN104853746A CN104853746A (zh) 2015-08-19
CN104853746B true CN104853746B (zh) 2018-02-23

Family

ID=47428789

Family Applications (2)

Application Number Title Priority Date Filing Date
CN201280077293.2A Active CN104853746B (zh) 2012-11-27 2012-11-27 用于治疗红斑痤疮的组合物
CN201810145665.XA Pending CN108159425A (zh) 2012-11-27 2012-11-27 用于治疗红斑痤疮的组合物

Family Applications After (1)

Application Number Title Priority Date Filing Date
CN201810145665.XA Pending CN108159425A (zh) 2012-11-27 2012-11-27 用于治疗红斑痤疮的组合物

Country Status (7)

Country Link
EP (1) EP2925296B1 (cg-RX-API-DMAC7.html)
JP (1) JP6423355B2 (cg-RX-API-DMAC7.html)
CN (2) CN104853746B (cg-RX-API-DMAC7.html)
CA (2) CA3051403C (cg-RX-API-DMAC7.html)
ES (1) ES2861431T3 (cg-RX-API-DMAC7.html)
MX (1) MX376183B (cg-RX-API-DMAC7.html)
WO (1) WO2014083557A1 (cg-RX-API-DMAC7.html)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2017068673A1 (ja) * 2015-10-21 2017-04-27 マルホ株式会社 皮膚用の医薬組成物
EP3426706A1 (en) 2016-03-08 2019-01-16 Living Proof, Inc. Long lasting cosmetic compositions
JP2020527140A (ja) * 2017-07-12 2020-09-03 ソル − ゲル テクノロジーズ リミテッド カプセル化トレチノインを含む組成物
US10987300B2 (en) 2017-09-13 2021-04-27 Living Proof, Inc. Long lasting cosmetic compositions
EP3681921A2 (en) 2017-09-13 2020-07-22 Living Proof, Inc. Color protectant compositions
US12029805B2 (en) 2017-11-20 2024-07-09 Living Proof, Inc. Properties for achieving long-lasting cosmetic performance
EP3784711A1 (en) 2018-04-27 2021-03-03 Living Proof, Inc. Long lasting cosmetic compositions
EP3586849A1 (en) 2018-06-29 2020-01-01 Aprofol AG Folate preparations
JP6811213B2 (ja) * 2018-07-03 2021-01-13 ソル − ゲル テクノロジーズ リミテッド 酒さの治療のための組成物
CA3130437A1 (en) 2019-02-19 2020-08-27 Sol-Gel Technologies Ltd. Method for treatment of rosacea

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008093346A2 (en) * 2007-02-01 2008-08-07 Sol-Gel Technologies Ltd. Compositions for topical application comprising a peroxide and retinoid
CN101605537A (zh) * 2006-11-28 2009-12-16 盖尔德马研究及发展公司 含有过氧化苯甲酰、至少一种萘甲酸的衍生物和至少一种聚氨酯聚合物类型的化合物或其衍生物的组合物及其用途
WO2012037000A1 (en) * 2010-09-15 2012-03-22 Norac, Pharma Benzoyl peroxide composition, methods of making same, and pharmaceutical or cosmetic formulations comprising same, and uses thereof

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10182378T1 (de) * 2000-04-21 2012-02-02 Sol-Gel Technologies Ltd. Zusammensetzung mit erhöter Formulationsstabilität und Verabreichung von topischen Wirkstoffen
GB0301577D0 (en) * 2003-01-23 2003-02-26 Edko Pazarlama Tanitim Ltd Sti Topical pharmaceutical and/or cosmetic dispense systems
FR2886850B1 (fr) 2005-06-10 2007-10-05 Galderma Sa Composition a base d'une avermectine et de peroxyde de benzoyle notamment pour le traitement de la rosacee
WO2008057411A1 (en) * 2006-11-02 2008-05-15 Stiefel Laboratories, Inc. Kits containing benzoyl peroxide pads and another acne-treating composition, and formulations and methods of use therefor
FR2910320B1 (fr) * 2006-12-21 2009-02-13 Galderma Res & Dev S N C Snc Emulsion comprenant au moins un retinoide et du peroxyde de benzole
EP2545776A3 (en) * 2007-02-01 2014-12-24 Sol-Gel Technologies Ltd. Method for preparing particles comprising metal oxide coating and particles with metal oxide coating
CN101969923A (zh) * 2007-11-30 2011-02-09 盖尔德马研究及发展公司 含有至少一种萘甲酸衍生物、过氧化苯甲酰和至少一种成膜剂的组合物、它们的制备方法及其用途
AU2009255679B2 (en) * 2008-06-05 2015-04-09 Dow Pharmaceutical Sciences, Inc. Topical pharmaceutical formulations containing a low concentration of benzoyl peroxide in suspension in water and a water-miscible organic solvent
EP2307129A2 (en) * 2008-07-31 2011-04-13 Sol-Gel Technologies Ltd. Microcapsules comprising active ingredients and a metal oxide shell, a method for their preparation and uses thereof
JP2012514593A (ja) * 2009-01-05 2012-06-28 ゾル−ゲル テクノロジー リミテッド 被覆した活性剤を含む局所組成物
RU2572693C2 (ru) * 2009-10-21 2016-01-20 Дау Фармасьютикал Сайенсиз, Инк. Способ смачивания порошка, содержащего пероксид бензоила
ES2611499T3 (es) * 2009-12-31 2017-05-09 Sol-Gel Technologies Ltd. Microcápsulas de núcleo estabilizado, procedimiento para su preparación y usos de las mismas

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101605537A (zh) * 2006-11-28 2009-12-16 盖尔德马研究及发展公司 含有过氧化苯甲酰、至少一种萘甲酸的衍生物和至少一种聚氨酯聚合物类型的化合物或其衍生物的组合物及其用途
WO2008093346A2 (en) * 2007-02-01 2008-08-07 Sol-Gel Technologies Ltd. Compositions for topical application comprising a peroxide and retinoid
WO2012037000A1 (en) * 2010-09-15 2012-03-22 Norac, Pharma Benzoyl peroxide composition, methods of making same, and pharmaceutical or cosmetic formulations comprising same, and uses thereof

Also Published As

Publication number Publication date
MX376183B (es) 2025-03-07
EP2925296B1 (en) 2021-01-06
JP2016501205A (ja) 2016-01-18
JP6423355B2 (ja) 2018-11-14
MX2015005515A (es) 2015-07-17
CA3051403A1 (en) 2014-06-05
CA3051403C (en) 2021-07-20
ES2861431T3 (es) 2021-10-06
CA2889199A1 (en) 2014-06-05
CN104853746A (zh) 2015-08-19
WO2014083557A1 (en) 2014-06-05
CN108159425A (zh) 2018-06-15
EP2925296A1 (en) 2015-10-07
CA2889199C (en) 2020-05-19

Similar Documents

Publication Publication Date Title
US20200405665A1 (en) Methods for the treatment of rosacea
CN104853746B (zh) 用于治疗红斑痤疮的组合物
JP2015518031A (ja) レチノイド含有マイクロカプセル、その調製方法、及び当該レチノイド含有マイクロカプセルを含む医薬組成物
US20230364050A1 (en) Method for treatment of rosacea including patient reported outcomes thereof
EP3337472A1 (en) Compositions for topical application comprising benzoyl peroxide and adapalene
JP6811213B2 (ja) 酒さの治療のための組成物

Legal Events

Date Code Title Description
PB01 Publication
EXSB Decision made by sipo to initiate substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant